Tailong Pharmaceutical (600222.SH) disclosed its report for the first quarter of 2024. The company achieved revenue of 4.9 during the reporting period...
According to the Zhitong Finance App, Tailong Pharmaceutical (600222.SH) disclosed its report for the first quarter of 2024. During the reporting period, the company achieved revenue of 499 million yuan, a year-on-year decrease of 10.92%; net profit to mother was 21.26 million yuan, an increase of 477.28% year on year; after deducting non-net profit of 18.96 million yuan, an increase of 449.09% year on year. Basic earnings per share were $0.0381. It is proposed to distribute a cash dividend of $0.18 (tax included) for every 10 shares.